Technology & Engineering

Research

The Latest

BPA’s Real Threat May Be After It Has Metabolized

Bisphenol A (BPA) is a synthetic chemical widely used in the making of plastic products ranging from bottles and food can linings to toys and water supply lines. When these plastics degrade, BPA is released into the environment and routinely ingested. New research from the University of California, San Diego School of Medicine suggests it’s the metabolic changes that take place once BPA is broken down inside the body that pose the greater health threat.

UC San Diego Sulpizio Cardiovascular Center Named One of Nation’s Top Heart Hospitals

UC San Diego Sulpizio Cardiovascular Center has been named one of the nation’s 50 Top Cardiovascular Hospitals by Truven Health Analytics. The Truven study examined the performance of more than 1,000 hospitals by analyzing outcomes for patients with heart failure and heart attacks and for those who received coronary bypass surgery and percutaneous coronary interventions such as angioplasties.

Blocking Tumor-Induced Inflammation Impacts Cancer Development

Researchers at the University of California, San Diego School of Medicine report the discovery of microbial–dependent mechanisms through which some cancers mount an inflammatory response that fuels their development and growth.

Health Technologies Top List of New Calit2 Research Grants to UC San Diego Faculty

The University of California, San Diego division of the California Institute for Telecommunications and Information Technology (Calit2) has given the green light to 17 new projects funded through the Calit2 Strategic Research Opportunities (CSRO) program. All told, the winning proposals garnered more than $826,000 in support from Calit2 for the year-long projects, effective October 1, 2012.

Common RNA Pathway Found in ALS and Dementia

Two proteins previously found to contribute to ALS, also known as Lou Gehrig’s disease, have divergent roles. But a new study, led by researchers at the Department of Cellular and Molecular Medicine at the University of California, San Diego School of Medicine, shows that a common pathway links them.

UCSD-based Cancer Consortium Receives 5-Year, $20 Million Grant Renewal

An international consortium of scientists studying chronic lymphocytic leukemia (CLL), based at the University of California, San Diego School of Medicine, has been awarded a 5-year, $20 million grant by the National Cancer Institute, part of the National Institutes of Health. The grant is the second renewal of funding for a broad-based effort designed to better understand the pathology of CLL – the most common form of leukemia in the Western world – and develop new drugs and treatments.